RADX TECH PROJECT, L3 HEALTHCARE, LLC: RADX PERFORMANCE EVALUATION OF YUKON SWABS

RADX TECH PROJECT, L3 HEALTHCARE, LLC：育空地区拭子的 RADX 性能评估

• 批准号: 10506141
• 负责人: CHERMAEN CLINDBERG
• 金额: $ 17.3万
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-01-12 至 2021-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10506141
• 关键词: American; COVID-19; COVID-19 detection; COVID-19 diagnostic; COVID-19 testing; Centers for Disease Control and Prevention (U.S.); Clinical; Contracts; Department of Defense; Development; Device Designs; Diagnostic tests; Ensure; Evaluation; Exhalation; Funding; Goals; Healthcare; Home; Improve Access; Laboratories; Life Cycle Stages; Modification; National Institute of Biomedical Imaging and Bioengineering; Patients; Performance; Point of Care Technology; Privatization; Program Development; RADx; RADx Tech; Readiness; Research; Saliva; Sampling; Seasons; Sensitivity and Specificity; Speed; Structure; Swab; Technology; Test Result; Testing; Time; TimeLine; United States National Institutes of Health; Validation; Virus; Yukon Territory; base; commercialization; cost; design; detection limit; flu; handheld mobile device; home test; improved; innovation; meetings; novel; point of care; product development; programs; scale up; technology development; user-friendly

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has an open solicitation for proposals to provide up to $500 million across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.

美国国家生物医学成像和生物工程研究所（NIBIB）公开征集建议，为多个项目提供高达5亿美元的资金，以快速生产创新的SARS-CoV-2诊断测试，帮助公众安全恢复正常活动。快速诊断加速（RADx）是一项快速技术开发计划，利用了美国国立卫生研究院（NIH）的床旁技术研究网络（POCTRN）。RADx将支持新的解决方案，使美国的SARS-CoV-2测试能力比标准方法高出100倍。RADx的结构是最早在2020年夏末向公众提供创新的测试策略，是NIH加速和全面的多管齐下的努力，使SARS-CoV-2测试随时可供每个美国人使用。